Register
Romosozumab treatment enhances BMD in men with osteoporosis |
Journal Updates
eMediNexus Coverage from: 
Romosozumab treatment enhances BMD in men with osteoporosis
eMediNexus,  11 July 2018
remove_red_eye 491 Views
#Diabetes and Endocrinology #Orthopedics #Rheumatology


comment                   
        



Romosozumab improves bone mineral density (BMD) in men with osteoporosis, according to results from the BRIDGE (placeBo-contRolled double-blind study evaluatIng the efficacy anD safety of romosozumab in treatinG mEn with osteoporosis) trial reported online June 20, 2018 in The Journal of Clinical Endocrinology and Metabolism. One year treatment with 210 mg SC QM romosozumab increased spine and hip BMD compared with placebo and was well tolerated.


Comments

Comments on eMediNexus are moderated. We retain the right to remove any comments at our sole discretion.